All Insights

Life Sciences and Healthcare

From hemp to highs: an overview of cannabis and CBD legislation across Europe

What are the key differences and overlaps across the European regulatory frameworks?
Urban Dynamics

Future Foods Update | January 2024

This month's edition includes novel food authorisations in Europe, IP in meat terminology, supply of service contracts, venture capital investment
Life Sciences and Healthcare

Novel food regulations permit the arrival of insect flour in Italy

Italy publishes four ministerial decrees regulating the labelling and sale of products using insect meal, that go further than EU
Life Sciences and Healthcare

Veterinary medicines in Italy: what's new?

Transparency List for generics is published and new legislation harmonising EU laws on veterinary medical products with national law is
Regulatory Outlook

Products | UK Regulatory Outlook January 2024

General Product Safety Regulation comes into effect | Right to repair – what's next in 2024? | UK's new International
Regulatory Outlook

Food law | UK Regulatory Outlook January 2024

Food label changes for non-UK FBOs | Increasing scrutiny and enforcement for greenwashing relating to food | Uncertainty on food
Regulatory and compliance

The new debarment regime for UK public procurement: how contracting authorities can avoid the pitfalls

What will the Procurement Act's introduction of a new debarment list for suppliers entail for contracting authorities?
Regulatory and compliance

Direct awards get post-pandemic overhaul under the new UK Procurement Act

UK ministers have been given sweeping new powers to bypass procurement rules to 'protect life'
Regulatory and compliance

Changes to the UK public procurement regimes set to deliver digital healthcare in the NHS

The huge potential of AI and data will help to drive efficiencies, improve patient outcomes and reduce spend
Regulatory and compliance

The next milestone approaches in the UK NHS net zero supplier roadmap

From April 2024, the NHS will proportionately extend the requirement for suppliers to prepare Carbon Reduction Plans to all procurements
Life Sciences and Healthcare

Using health data for R&D and AI: will new legislation make this possible in Germany?

The new health-data bill currently debated by the German lawmakers could be adopted this year and apply from early 2024
Life Sciences and Healthcare

Digital therapeutics in Europe: what is the state of play?

The regulatory landscape varies, but the potential for the sector is immense